Tumor Biology
ISSN 1010-4283 · SAGE Publishing · United Kingdom · active 1985–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Tumor Biology a predatory journal?
Our screening does not flag Tumor Biology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, PubMed, which is a positive signal.
Is Tumor Biology indexed in Scopus or Web of Science?
Per our venue index, Tumor Biology appears in: DOAJ, Scopus, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Tumor Biology's impact?
Papers in Tumor Biology are cited about 2.9 times each within two years of publication, and Scimago places it in Q2, with an h-index of 122. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Tumor Biology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.